GT Biopharma GTBP
NASDAQ GTBP
$5.41 -1.90 (-25.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Operating Leases (2022 - 2023)

Updated

GT Biopharma (GTBP) posted Operating Leases of $31,000 for Q1 2023, down 78.9% from $147,000 a year earlier and down 51.6% from the prior quarter.

Analysis

GT Biopharma (GTBP) Operating Leases (2022 - 2023) Analysis & Trends

At the end of FY2022, GT Biopharma's Operating Leases came in at $64,000.

  • According to Business Quant data, Operating Leases for the three prior quarters was $64,000 (Q4 2022), $92,000 (Q3 2022) and $120,000 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 GT Biopharma 6.53 Mn -16.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 31,000.00
Dec 31, 2022 64,000.00
Sep 30, 2022 92,000.00
Jun 30, 2022 120,000.00
Mar 31, 2022 147,000.00
API Access

GT Biopharma Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GTBP&period=max&api_key=YOUR_API_KEY